Recent progress in neurodegenerative disorder research in China

Science China Life Sciences

Volumn 53, Issue 3, 2010, Pages 348-355

  Zhou, JiaWei ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Alzheimer's disease; Diagnosis; Neurodegenerative disorders; Neuroprotection; Parkinson's disease; Pathogenesis

Indexed keywords

ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; BRAIN; CHINA; DEGENERATIVE DISEASE; HUMAN; METABOLISM; PARKINSON DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS; BRAIN; CHINA; HUMANS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 77951962298     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-010-0061-0     Document Type: Review

References (43)

1. Zhang Z X, Roman G C, Hong Z, et al. Parkinson's disease in China: Prevalence in Beijing, Xian, and Shanghai. Lancet, 2005, 365: 595-597.
2. Wang G, Cheng Q, Zhang S, et al. Economic impact of dementia in developing countries: An evaluation of Alzheimer-type dementia in Shanghai, China. J Alzheimers Dis, 2008, 15: 109-115.
3. Guo J F, Xiao B, Liao B, et al. Mutation analysis of Parkin, PINK1, DJ-1 and ATP13A2 genes in Chinese patients with autosomal recessive early-onset Parkinsonism. Mov Disord, 2008, 23: 2074-2079.
4. Cong L, Jia J. Promoter polymorphisms which regulate ADAM9 transcription are protective against sporadic Alzheimer's disease. Neurobiol Aging, 2009, online available on Feb. 21, 2009.
5. Zhao G H, Hu Z M, Shen L, et al. A novel candidate locus on chromosome 11p14. 1-p11. 2 for autosomal dominant hereditary spastic paraplegia. Chin Med J (Engl), 2008, 121: 430-434.
6. Zhang C E, Wei W, Liu Y H, et al. Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol, 2009, 174: 1481-1491.
7. Zhang C E, Tian Q, Wei W, et al. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol Aging, 2008, 29: 1654-1665.
8. Zhang Y J, Xu Y F, Liu Y H, et al. Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms. Faseb J, 2006, 20: 1431-1442.
9. Qu M H, Li H, Tian R, et al. Neuronal tau induces DNA conformational changes observed by atomic force microscopy. Neuroreport, 2004, 15: 2723-2727.
10. Li W, Wang X S, Qu M H, et al. Human protein tau represses DNA replication in vitro. Biochim Biophys Acta, 2005, 1726: 280-286.
11. Hua Q, He R Q. Tau could protect DNA double helix structure. Biochim Biophys Acta, 2003, 1645: 205-211.
12. Nie C L, Wang X S, Liu Y, et al. Amyloid-like aggregates of neuronal tau induced by formaldehyde promote apoptosis of neuronal cells. BMC Neurosci, 2007, 8: 9.
13. Zhang H, Loovers H M, Xu L Q, et al. Alcohol oxidase (AOX1) from Pichia pastoris is a novel inhibitor of prion propagation and a potential ATPase. Mol Microbiol, 2009, 71: 702-716.
14. Lian H Y, Zhang H, Zhang Z R, et al. Hsp40 interacts directly with the native state of the yeast prion protein Ure2 and inhibits formation of amyloid-like fibrils. J Biol Chem, 2007, 282: 11931-11940.
15. Zhu L Q, Wang S H, Liu D, et al. Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J Neurosci, 2007, 27: 12211-12220.
16. Liu G P, Zhang Y, Yao X Q, et al. Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms. Neurobiol Aging, 2008, 29: 1348-1358.
17. Li H L, Wang H H, Liu S J, et al. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc Natl Acad Sci USA, 2007, 104: 3591-3596.
18. Hong Z, Zhang Q Y, Liu J, et al. Phosphoproteome study reveals Hsp27 as a novel signaling molecule involved in GDNF-induced neurite outgrowth. J Proteom Res, 2009, available online 16 March, 2009.
19. Wang J Z, Liu F. Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol, 2008, 85: 148-175.
20. Hou H L, Shen Y X, Zhu H Y, et al. Alterations of hHrd1 expression are related to hyperphosphorylated tau in the hippocampus in Alzheimer's disease. J Neurosci Res, 2006, 84: 1862-1870.
21. Zhu H Y, Guo H F, Hou H L, et al. Increased expression of the Nogo receptor in the hippocampus and its relation to the neuropathology in Alzheimer's disease. Hum Pathol, 2007, 38: 426-434.
22. Lu Y P, Zeng M, Hu X Y, et al. Estrogen receptor alpha-immunore-active astrocytes are increased in the hippocampus in Alzheimer's disease. Exp Neurol, 2003, 183: 482-488.
23. Wang J, Jiang H, Xie J X. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats. Eur J Neurosci, 2007, 25: 2766-2772.
24. Zhu W Z, Zhong W D, Wang W, et al. Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology, 2009, 253: 497-504.
25. Jia J P, Meng R, Sun Y X, et al. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia. Neurosci Lett, 2005, 383: 12-16.
26. Stanley C J, Johannsson A, Self C H. Enzyme amplification can enhance both the speed and the sensitivity of immunoassays. J Immunol Methods, 1985, 83: 89-95.
27. Hu Y Y, He S S, Wang X, et al. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients: an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am J Pathol, 2002, 160: 1269-1278.
28. Du Y, Li X, Yang D, et al. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo. Exp Biol Med (Maywood), 2008, 233: 881-890.
29. Chen Z Y, He Z Y, He C, et al. Human glial cell-line-derived neurotrophic factor: a structure-function analysis. Biochem Biophys Res Commun, 2000, 268: 692-696.
30. Wang L M, Zhang Q, Zhu W, et al. Identification of the key amino acids of glial cell line-derived neurotrophic factor family receptor alpha1 involved in its biological function. J Biol Chem, 2004, 279: 109-116.
31. Zhang Y, Zhu W, Wang Y G, et al. Interaction of SH2-Bbeta with RET is involved in signaling of GDNF-induced neurite outgrowth. J Cell Sci, 2006, 119: 1666-1676.
32. Xu L, Sheng J, Tang Z, et al. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Neurobiol Dis, 2005, 18: 152-165.
33. Zhang J, Liu Q, Chen Q, et al. Nicotine attenuates beta-amyloid- induced neurotoxicity by regulating metal homeostasis. FASEB J, 2006, 20: 1212-1214.
34. Xie Y X, Bezard E, Zhao B L. Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria. J Biol Chem, 2005, 280: 32405-32412.
35. Sun Z K, Yang H Q, Pan J, et al. Protective effects of erythropoietin on tau phosphorylation induced by beta-amyloid. J Neurosci Res, 2008, 86: 3018-3027.
36. Wang G, Pan J, Tan Y Y, et al. Neuroprotective effects of PACAP27 in mice model of Parkinson's disease involved in the modulation of K(ATP) subunits and D2 receptors in the striatum. Neuropeptides, 2008, 42: 267-276.
37. Luo X Y, Zhang X H, Shao W, et al. Crucial roles of MZF-1 in the transcriptional regulation of apomorphine-induced modulation of FGF-2 expression in astrocytic cultures. J Neurochem 2009, accepted.
38. Yin J, Liu Y H, Xu Y F, et al. Melatonin arrests peroxynitrite-induced tau hyperphosphorylation and the overactivation of protein kinases in rat brain. J Pineal Res, 2006, 41: 124-129.
39. Wang X, Liang X B, Li F Q, et al. Therapeutic strategies for Parkinson's disease: the ancient meets the future-traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells. Neurochem Res, 2008, 33: 1956-1963.
40. Zhou H F, Liu X Y, Niu D B, et al. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiol Dis, 2005, 18: 441-449.
41. Hong Z, Wang G, Gu J, et al. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice. Eur J Neurosci, 2007, 26: 1500-1508.
42. Guo S, Yan J, Yang T, et al. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway. Biol Psychiatry, 2007, 62: 1353-1362.
43. Zhang L, Jie G, Zhang J, et al. Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress. Free Radic Biol Med, 2009, 46: 414-421.